Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Accelerate Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Accelerate Diagnostics Inc Company Overview
- Accelerate Diagnostics Inc Company Snapshot
- Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Accelerate Diagnostics Inc - Pipeline Analysis Overview
- Business Description
- Accelerate Diagnostics Inc - Key Facts
- Accelerate Diagnostics Inc - Major Products and Services
- Accelerate Diagnostics Inc Pipeline Products by Development Stage
- Accelerate Diagnostics Inc Pipeline Products Overview
- Accelerate ARC System
- Accelerate ARC System Product Overview
- Accelerate ID/AST System - Antibiotic-Resistant Biothreat Agents
- Accelerate ID/AST System - Antibiotic-Resistant Biothreat Agents Product Overview
- Accelerate ID/AST System - Carbepenem Resistance Testing
- Accelerate ID/AST System - Carbepenem Resistance Testing Product Overview
- Accelerate ID/AST System - Secondary Infections
- Accelerate ID/AST System - Secondary Infections Product Overview
- Accelerate ID/AST System - Wound Infections
- Accelerate ID/AST System - Wound Infections Product Overview
- Accelerate Pheno System - Intra-Abdominal Infections Assay
- Accelerate Pheno System - Intra-Abdominal Infections Assay Product Overview
- Accelerate Pheno System - Urinary Tract Infections Assay
- Accelerate Pheno System - Urinary Tract Infections Assay Product Overview
- BAC-Xtrax System
- BAC-Xtrax System Product Overview
- Lower Respiratory Kit
- Lower Respiratory Kit Product Overview
- Pheno 2.0 System
- Pheno 2.0 System Product Overview
- Accelerate Diagnostics Inc - Key Competitors
- Accelerate Diagnostics Inc - Key Employees
- Accelerate Diagnostics Inc - Key Employee Biographies
- Accelerate Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Accelerate Diagnostics Inc, Recent Developments
- May 11, 2023: Accelerate Diagnostics reports first quarter 2023 financial results
- Mar 15, 2023: Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results
- Mar 14, 2023: Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement
- Mar 08, 2023: Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors
- Nov 14, 2022: Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
- May 23, 2022: Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022
- May 16, 2022: Accelerate Diagnostics Reports First Quarter 2022 Financial Results
- Mar 29, 2022: Accelerate Diagnostics launches Arc system for use in blood culture test
- Mar 08, 2022: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results
- Feb 24, 2022: Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Accelerate Diagnostics Inc Pipeline Products by Equipment Type
- Accelerate Diagnostics Inc Pipeline Products by Indication
- Accelerate Diagnostics Inc, Key Facts
- Accelerate Diagnostics Inc, Major Products and Services
- Accelerate Diagnostics Inc Number of Pipeline Products by Development Stage
- Accelerate Diagnostics Inc Pipeline Products Summary by Development Stage
- Accelerate ARC System - Product Status
- Accelerate ARC System - Product Description
- Accelerate ID/AST System - Antibiotic-Resistant Biothreat Agents - Product Status
- Accelerate ID/AST System - Antibiotic-Resistant Biothreat Agents - Product Description
- Accelerate ID/AST System - Carbepenem Resistance Testing - Product Status
- Accelerate ID/AST System - Carbepenem Resistance Testing - Product Description
- Accelerate ID/AST System - Secondary Infections - Product Status
- Accelerate ID/AST System - Secondary Infections - Product Description
- Accelerate ID/AST System - Wound Infections - Product Status
- Accelerate ID/AST System - Wound Infections - Product Description
- Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Status
- Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Description
- Accelerate Pheno System - Urinary Tract Infections Assay - Product Status
- Accelerate Pheno System - Urinary Tract Infections Assay - Product Description
- BAC-Xtrax System - Product Status
- BAC-Xtrax System - Product Description
- Lower Respiratory Kit - Product Status
- Lower Respiratory Kit - Product Description
- Pheno 2.0 System - Product Status
- Pheno 2.0 System - Product Description
- Accelerate Diagnostics Inc, Key Employees
- Accelerate Diagnostics Inc, Key Employee Biographies
- Accelerate Diagnostics Inc, Other Locations
- Accelerate Diagnostics Inc, Subsidiaries
- Glossary
- Accelerate Diagnostics Inc Pipeline Products by Equipment Type
- Accelerate Diagnostics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton Dickinson and Co
- Bruker Corp
- Luminex Corp
- T2 Biosystems Inc
- Danaher Corp
- bioMerieux SA
